Home

Systém Ztělesňovat ozón biologické markery v medicine kurz 28.3 Vzít ven Ohleduplný Integrovat

SenoMark™ UltraCor™ Breast Tissue Marker 14G x 13cm Needle, BioDur 108,  Venus Shape - SMUC13V | BD
SenoMark™ UltraCor™ Breast Tissue Marker 14G x 13cm Needle, BioDur 108, Venus Shape - SMUC13V | BD

Sborník abstrakt z neurochirurgického kurzu 2012
Sborník abstrakt z neurochirurgického kurzu 2012

Characterization of testis-specific serine/threoni... | proLékaře.cz
Characterization of testis-specific serine/threoni... | proLékaře.cz

Správa o činnosti organizácie SAV za rok 2020
Správa o činnosti organizácie SAV za rok 2020

Dobrodruh Křeslo Žadatel online shop s oblecenim seno Odříznout Amerika
Dobrodruh Křeslo Žadatel online shop s oblecenim seno Odříznout Amerika

Experimental Medicine - Developing biomarkers in early discovery to bridge  preclinical and clinical development - Drug Discovery World (DDW)
Experimental Medicine - Developing biomarkers in early discovery to bridge preclinical and clinical development - Drug Discovery World (DDW)

REVIEWs CoSMIC INHERITANCE RULES: IMPLICATIoNS FoR HEALTH CARE AND SCIENCE  . . . . . . . . . . . . . . . . . . . . . . . . . . .
REVIEWs CoSMIC INHERITANCE RULES: IMPLICATIoNS FoR HEALTH CARE AND SCIENCE . . . . . . . . . . . . . . . . . . . . . . . . . . .

Reactivities of the Front Pocket N-Terminal Cap Cysteines in Human Kinases  | Journal of Medicinal Chemistry
Reactivities of the Front Pocket N-Terminal Cap Cysteines in Human Kinases | Journal of Medicinal Chemistry

Overcoming Resistance to Targeted Anticancer Therapies through  Small-Molecule-Mediated MEK Degradation - ScienceDirect
Overcoming Resistance to Targeted Anticancer Therapies through Small-Molecule-Mediated MEK Degradation - ScienceDirect

Cancers | Free Full-Text | Targeted Tumor Therapy Remixed—An Update on the  Use of Small-Molecule Drugs in Combination Therapies
Cancers | Free Full-Text | Targeted Tumor Therapy Remixed—An Update on the Use of Small-Molecule Drugs in Combination Therapies

Dual-vector prodrug activator gene therapy using retroviral replicating  vectors | Cancer Gene Therapy
Dual-vector prodrug activator gene therapy using retroviral replicating vectors | Cancer Gene Therapy

Physical determinants of vault performance and the... | proLékaře.cz
Physical determinants of vault performance and the... | proLékaře.cz

Protein BIOMARKER Strategies - Drug Discovery World (DDW)
Protein BIOMARKER Strategies - Drug Discovery World (DDW)

Nádorové markery: Patria do koša, alebo ich vieme efektívne využiť v  laboratórnej diagnostike a v klinike? | Unilabs
Nádorové markery: Patria do koša, alebo ich vieme efektívne využiť v laboratórnej diagnostike a v klinike? | Unilabs

Tulathromycin treatment does not affect bacterial... | proLékaře.cz
Tulathromycin treatment does not affect bacterial... | proLékaře.cz

JCDD | Free Full-Text | A Story of PA/BSA and Biomarkers to Diagnose  Pulmonary Hypertension in Patients with Severe Aortic Valve  Stenosis—The Rise of IGF-BP2 and GDF-15
JCDD | Free Full-Text | A Story of PA/BSA and Biomarkers to Diagnose Pulmonary Hypertension in Patients with Severe Aortic Valve Stenosis—The Rise of IGF-BP2 and GDF-15

Characterization of testis-specific serine/threoni... | proLékaře.cz
Characterization of testis-specific serine/threoni... | proLékaře.cz

Zpravodaj biologie 2-2002 z.cdr
Zpravodaj biologie 2-2002 z.cdr

Eupolyphaga sinensis Walker displays inhibition on hepatocellular carcinoma  through regulating cell growth and metastasis signaling | Scientific Reports
Eupolyphaga sinensis Walker displays inhibition on hepatocellular carcinoma through regulating cell growth and metastasis signaling | Scientific Reports

titulná strana)
titulná strana)

REVIEWs CoSMIC INHERITANCE RULES: IMPLICATIoNS FoR HEALTH CARE AND SCIENCE  . . . . . . . . . . . . . . . . . . . . . . . . . . .
REVIEWs CoSMIC INHERITANCE RULES: IMPLICATIoNS FoR HEALTH CARE AND SCIENCE . . . . . . . . . . . . . . . . . . . . . . . . . . .

Výroční zpráva
Výroční zpráva

Výroční zpráva 2010
Výroční zpráva 2010

Správa o činnosti organizácie SAV za rok 2020
Správa o činnosti organizácie SAV za rok 2020

Správa o činnosti organizácie SAV za rok 2020
Správa o činnosti organizácie SAV za rok 2020

Výroční zpráva za rok 2003
Výroční zpráva za rok 2003